| Texto completo | |
| Autor(es): |
do Nascimento, Paulo Cainan Guimaraes
;
Martins, Matthews Silva
;
Improta-Caria, Alex Cleber
;
Aras Junior, Roque
Número total de Autores: 4
|
| Tipo de documento: | Artigo Científico |
| Fonte: | Arquivos Brasileiros de Cardiologia; v. 122, n. 8, p. 10-pg., 2025-01-01. |
| Resumo | |
Background: Machine Learning (ML) is a type of algorithm that autonomously learns to recognize complex patterns. In the diagnostic context of cardiac arrhythmias, these algorithms have shown significant advancements due to their ability to provide automated interpretation and pattern recognition in electrocardiograms (ECGs). Objective: To analyze and identify the applicability, validity, and feasibility of ML algorithm models in the diagnostic process of cardiac arrhythmias through automated electrocardiogram interpretation. Methods: This systematic literature review was reported according to the PRISMA guidelines. The searches were conducted in the Cochrane Library, EMBASE, LILACS, and PubMed between February 2022 and November 2022. The study period encompasses articles published between 2017 and 2022. Results: The database search yielded 119 results, covering three subthemes: Long QT Syndrome (LQTS), corrected QT interval (QTc), and atrial fibrillation (AF). AF was the most prevalent theme. The sample sizes were quite variable. The outcomes were mostly satisfactory. In the diagnosis of LQTS using Artificial Intelligence (AI), the algorithm outperformed conventional methods in diagnostic distinction. In the evaluation of QTc, there was no difference between the AIintegrated ECG and the conventional ECG. In the diagnosis of AF, the algorithms, models, and devices demonstrated high sensitivity and specificity, along with greater accuracy. Conclusion: ML models in the diagnostic process of cardiac arrhythmias are feasible and rapidly developing. They demonstrate accuracy values between 96.4% and 98.2%, sensitivity between 92.8% and 99.4%, and specificity between 95% and 98.1%, particularly in the diagnosis of atrial fibrillation. (AU) | |
| Processo FAPESP: | 22/02339-4 - MicroRNAs regulados pelo treinamento físico como potenciais biomarcadores e terapêuticos da cardiotoxicidade induzida pela doxorrubicina no Câncer de Mama: estudo in vivo, in vitro em cardiomiócitos derivados de iPS e clínico com análise em pacientes |
| Beneficiário: | Alex Cleber Improta Caria |
| Modalidade de apoio: | Bolsas no Brasil - Pós-Doutorado |
| Processo FAPESP: | 24/17783-2 - MicroRNAs como terapêuticos da cardiotoxicidade em co-cultura de cardiomiócitos humanos com fibroblastos cardíacos humanos estimulados com doxorrubicina. |
| Beneficiário: | Alex Cleber Improta Caria |
| Modalidade de apoio: | Bolsas no Exterior - Estágio de Pesquisa - Pós-Doutorado |